None Better than One? (A Brief Note on VC in Smaller Hubs)
Biotech venture funding metrics continue at historic highs, highlighting that the robust financing environment…
VC
There are 12 articles under this tag
Could Pharma/Biotech Build an Amazon?
Pharma/Biotech Business Model Innovation When I hear/read about business model innovation in pharma/biotech, the themes…
Is Biotech Venture Capital Dying?
This post was inspired by the Xconomy story Wisconsin 2013 VC Activity Drops, Shifts…
Early Stage Biotech Investing in Wisconsin: Hot or Not?
In this post, I want to look at funding, particularly via angel investing, of…
WI VC Investment: Down (& Out?) in Q3 ’13
The venture capital investment numbers are out for the Q3 2013 (courtesy of NVCA & PwC). I am usually…
Engineering Capital Flow: Thoughts on Wisconsin & Beyond
Late last month there was a formal announcement of a new $30 million information…
Madison Tech: Opportunity to Recycle?
An interesting question that came up at the Spring Tech Kickoff last week: what…
Biotech Venture Capital – EOY2012
A challenge with data is that the collection methods are critical when you are…
Investing in Long Distance Relationships in Wisconsin
In my previous post about 2012 investment capital in Wisconsin, I asserted and supported…
2012 Wisconsin Investment Capital Roundup
The fourth quarter venture capital investment numbers came out, which prompted me to update…
Load More